FDA feels the heat over heparin


About the Video

The FDA was in the hot seat after a tainted drug was implicated in multiple deaths. A recent study found that more than 80% of active ingredients in U.S. drugs come from abroad, but only 11% of foreign suppliers are investigated by the FDA. April 2008

Terms & Rules

As per ASIC Regulatory Guide 162: All investment tips and comments appearing on this website (Poll results, BLOGS & discussion forums) are submitted by the general public who are not licensed financial advisors. None of the information on this website is financial or investment advice, you should seek independent financial or investment advice by a licensed financial or investment advisor before entering into any position of financial risk. Before using this website, you must agree to the BioInvesting.com.au Terms Of Use

Before using this Biomedical Investing website

OR